CEMEX (NYSE: CX ) is expected to report Q2 earnings on July 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict CEMEX's revenues will grow 2.9% and EPS will come to zero.
The average estimate for revenue is $3.97 billion. On the bottom line, the average EPS estimate is $0.00.
Last quarter, CEMEX booked revenue of $3.32 billion. GAAP reported sales were 3.7% lower than the prior-year quarter's $3.53 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.24. GAAP EPS were -$0.25 for Q1 compared to -$0.03 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 27.4%, 50 basis points better than the prior-year quarter. Operating margin was 6.6%, 20 basis points better than the prior-year quarter. Net margin was -8.5%, 770 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $15.70 billion. The average EPS estimate is -$0.19.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 3,716 members out of 3,874 rating the stock outperform, and 158 members rating it underperform. Among 1,024 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 995 give CEMEX a green thumbs-up, and 29 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on CEMEX is outperform, with an average price target of $11.68.
Looking for alternatives to CEMEX? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add CEMEX to My Watchlist.